Back
Published on 11/12/2024
Extens, the dedicated European software investor for healthcare, announces the sale of Teranga to Orisha, a European software publisher serving the healthcare, real estate, retail, construction, and agrifood sectors, supported by Francisco Partners and TA Associates. With Extens’ support, Teranga has established itself as a key player in the French medico-social sector.
A Success Story in the Medico-Social Sector
Based in Paris and employing nearly 150 staff, Teranga has developed a comprehensive and user-friendly SaaS software suite designed for nursing homes, senior residences, disability care structures, child protection structures, special needs structures, integration and emergency housing. Today, the software is used by over 5,000 institutions.
A leader in its historical market segment for elderly care facilities with its flagship solution NetSoins, Teranga has expanded its offerings to include disability care facilities with NETVie. This solution centralizes all data related to resident care, including personalized care plans, activity planning, educational and medical records, and prescriptions.
Leveraging its specialized platform for patient care management, Teranga has developed complementary modules and ERP solutions addressing all essential needs of medico-social structures. These include NetContact for admission management, NetFactu for administrative and billing management, and NetPlanning for staff scheduling. These solutions are designed to meet the needs of caregivers, patients, and their families comprehensively.
Strong and Steady Growth with Extens
Extens joined Teranga’s capital in June 2018, alongside its founder and Bpifrance, with the aim of consolidating its leadership position in management software for nursing homes while diversifying its offerings into the disability and homecare sectors. During this period, Teranga’s revenue grew by 3x, reaching nearly EUR 25 million in 2024.
A Recognized Specialist Model
This sale to Orisha, supported by two leading international funds, once again highlights the quality of the assets developed by Extens and the relevance of its specialized investment model in healthcare software. Following the sale of Must last summer, this mark Extens’ second strategic exit in 2024.